By Professor Nada Hamad

Journal articles

Montoto S; Snowden JA; Chabannon C; Corbacioglu S; de la Camara R; Dolstra H; Greco R; Gusi A; Hamad N; Kenyon M; Kröger N; Mohty M; Murray J; Mueller A; Neven B; Peffault de Latour R; Peric Z; Sánchez-Ortega I; Sureda A; Verhoeven B; Villar A; Yakoub-Agha I, 2022, 'The first steps towards a diverse and inclusive EBMT: a position paper', Bone Marrow Transplantation, 57, pp. 343 - 346, http://dx.doi.org/10.1038/s41409-022-01586-w

Bishop MR; Dickinson M; Purtill D; Barba P; Santoro A; Hamad N; Kato K; Sureda A; Greil R; Thieblemont C; Morschhauser F; Janz M; Flinn I; Rabitsch W; Kwong YL; Kersten MJ; Minnema MC; Holte H; Chan EHL; Martinez-Lopez J; Müller AMS; Maziarz RT; McGuirk JP; Bachy E; Gouill SL; Dreyling M; Harigae H; Bond D; Andreadis C; McSweeney P; Kharfan-Dabaja M; Newsome S; Degtyarev E; Awasthi R; Del Corral C; Andreola G; Masood A; Schuster SJ; Jäger U; Borchmann P; Westin JR, 2022, 'Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma', New England Journal of Medicine, 386, pp. 629 - 639, http://dx.doi.org/10.1056/NEJMoa2116596

Zijlstra JM; Follows G; Casasnovas RO; Vermaat JSP; Kalakonda N; Choquet S; Hill B; Thieblemont C; Cavallo F; De la Cruz F; Kuruvilla J; Hamad N; Jaeger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vassilakopoulos TP; Samal P; Ku M; Xu J; Corona K; Chamoun K; Shah J; Canales M; Maerevoet M, 2022, 'The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study', Cancers, 14, http://dx.doi.org/10.3390/cancers14030791

Casasnovas RO; Follows G; Zijlstra JM; Vermaat JSP; Kalakonda N; Choquet S; Neste EVD; Hill B; Thieblemont C; Cavallo F; la Cruz FD; Kuruvilla J; Hamad N; Jaeger U; Caimi PF; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vassilakopoulos TP; Samal P; Ku M; Ma X; Chamoun K; Shah J; Canales M; Maerevoet M; Shacham S; Kauffman MG; Goy A, 2022, 'Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes', Clinical Lymphoma, Myeloma and Leukemia, 22, pp. 24 - 33, http://dx.doi.org/10.1016/j.clml.2021.07.017

Nivison-Smith I; Bajel A; Dodds AJ; Gottlieb D; Hamad N; Kennedy G; Kerridge I; Ma DDF; Milliken S; Moore J; Purtill D; Szer J, 2022, 'Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experience', Internal Medicine Journal, 52, pp. 57 - 62, http://dx.doi.org/10.1111/imj.15128

Mills G; Anderson MA; Tang C; Hamad N, 2022, 'The untold effect of the combined oral contraceptive pill on anticancer drugs', The Lancet Haematology, 9, pp. e10 - e11, http://dx.doi.org/10.1016/S2352-3026(21)00377-X

Harrop S; Di Ciaccio P; Doo NW; Cochrane T; Campbell BA; Hamad N; Dickinson M; Van Der Weyden C; Prince HM, 2022, 'The gamma delta lymphomas: an Australian multi-centre case series', Annals of Lymphoma, 6, pp. 3 - 3, http://dx.doi.org/10.21037/aol-21-41

Bishop MR; Dickinson M; Purtill D; Barba P; Santoro A; Hamad N; Kato K; Sureda A; Greil R; Thieblemont C; Morschhauser F; Janz M; Flinn IW; Rabitsch W; Kwong YL; Kersten MJ; Minnema MC; Holte H; Chan EHL; Martinez-Lopez J; Mueller AMS; Maziarz RT; McGuirk JP; Bachy E; Le Gouill S; Dreyling M; Harigae H; Bond DA; Andreadis C; McSweeney PA; Kharfan-Dabaja MA; Newsome S; Degtyarev E; Del Corral C; Andreola G; Masood A; Schuster SJ; Jaeger U; Borchmann P; Westin JR, 2021, 'Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study', Blood, 138, http://dx.doi.org/10.1182/blood-2021-155068

Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N, 2021, 'Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic', Transplantation and Cellular Therapy, 27, pp. 1022.e1 - 1022.e6, http://dx.doi.org/10.1016/j.jtct.2021.09.012

Maerevoet M; Zijlstra JM; Follows G; Casasnovas RO; Vermaat JSP; Kalakonda N; Goy A; Choquet S; Van Den Neste E; Hill B; Thieblemont C; Cavallo F; De la Cruz F; Kuruvilla J; Hamad N; Jaeger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vassilakopoulos TP; Samal P; Ku M; Ma X; Corona K; Chamoun K; Shah J; Shacham S; Kauffman MG; Canales M, 2021, 'Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study', Journal of Hematology and Oncology, 14, http://dx.doi.org/10.1186/s13045-021-01122-1

Chadwick VL; Mills G; Di Ciaccio PR; Tang C; Dear R; Moore J; Milliken S; Withers B; Lavee O; McCaughan GJ; Perram J; Hamad N, 2021, 'A Minority of Women of Child Bearing Potential Are Tested for Pregnancy before Chemoimmunotherapy: An Australian Cancer Centre Experience', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-154028

Mills G; Di Ciaccio PR; Tang C; Chadwick VL; Mason KD; Campbell B; Shanavas M; Morris KL; Greenwood M; Kidson-Gerber G; Eslick R; Badoux X; Yannakou CK; Gangatharan SA; Hamad N, 2021, 'Capturing the Lived Experiences of Women with Lymphoma in Pregnancy: An Australasian Lymphoma Alliance Study', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-152065

Wilson MR; Eyre TA; Kirkwood AA; Doo NW; Soussain C; Choquet S; Martinex-Calle N; Preston G; Ahearne MJ; Schorb E; Moles-Moreau M-P; Ku M; Rusconi C; Khwaja J; Narkhede M; Lewis KL; Calimeri T; Durot E; Renaud L; Ovlisen AK; McIlroy G; Ebsworth T; Elliot J; Santarsiere A; Ricard L; Shah N; Liu Q; Zayac A; Vassallo F; Lebras L; Roulin L; Lombion N; Manos K; Fernandez R; Hamad N; Lopez-Garcia A; O'Mahony D; Gounder P; Forgeard N; Lees C; Agbetiafa K; Struesmann T; Htut TW; Clavert A; Scott HW; Guidetti A; Barlow BR; Smith J; El-Galaly TC; Cheah CY; Ferreri AJM; Miall F; Fox CP; Cwynarski K; McKay P, 2021, 'Early Integration of High Dose Methotrexate to Frontline DLBCL Therapy Does Not Impact CNS Relapse Compared to End of Treat ent Delivery: A Multicentre International Analysis of 1384 Patients', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-144820

Di Ciaccio PR; Campbell B; Mason KD; Shanavas M; Greenwood M; Gregory GP; Eslick R; Kidson-Gerber G; Tang C; Morris KL; Smallbone P; Badoux X; Shipton MJ; McKeague SJ; Langfield J; Goss K; Hamad N, 2021, 'Lymphoma during Pregnancy: A Multicentre Study By the Australasian Lymphoma Alliance', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-150538

Perram J; Mayson E; Tang C; Tran S; Aarons D; Dodds AJ; Fay K; Hamad N; Ma D; Milliken S; Withers B; Greenwood M; Stevenson WS; Arthur CK; Kerridge IH; Moore J, 2021, 'Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-147106

Lee S; Locatelli F; Ayuk FA; Zuckerman T; Fukushima K; Llamas JCV; Pidala J; Hamad N; Moiseev IS; Bonifazi F; Apte S; Zeiser R; Bhatt V; Gowda M; Han J; Stefanelli T; Zuurman MW; Teshima T, 2021, 'Patient-Reported Outcomes (PROs) Among Patients With Steroid-Refractory or -Dependent Chronic Graft-vs-Host Disease (cGVHD) Randomized to Ruxolitinib (RUX) vs Best Available Therapy (BAT)', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-144576

Tatarczuch M; Lewis KL; Gunjur A; Shaw B; Poon M; Paul E; Ku M; Wong M; Beekman A; Krigstein M; Di Ciaccio PR; Wight J; Coombes C; Gilbertson M; Tey A; Shortt J; Nagarajan C; Latimer M; Talaulikar D; Hamad N; Ratnasingam S; Cochrane T; Hawkes E; Cheah CY; Opat S; Gregory GP, 2021, 'Real-World Outcomes of Patients with Primary CNS Lymphoma (PCNSL): A Report from the Australasian Lymphoma Alliance (ALA)', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-145959

Mills G; Tang C; Di Ciaccio PR; Chadwick VL; Withers B; Lavee O; Milliken S; Perram J; McCaughan GJ; Hamad N, 2021, 'Systematic Omission of Pregnant and Lactating Women from Malignant Haematology Trials Perpetuates a Cycle of Exclusion, Data Shortage and Disadvantage', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-149354

White J; Elemary M; Linn SM; Novitzky-Basso I; Xenocostas A; Hamad N; Culos S; Tan S; Law A; Kumar R; Mattsson J; Dennis D; Kim H, 2021, 'Update of Multicenter, Retrospective Evaluation of Overall Response and Failure Free Survival Following Ruxolitinib Therapy for Heavily Pre-Treated Chronic Gvhd Patients with Steroid-Failure: A Proposal of Risk Score Model for Failure-Free Survival', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-148859

Boyle S; Tobin JWD; Perram J; Hamad N; Gullapalli V; Barraclough A; Singaraveloo L; Han MH; Blennerhassett R; Nelson N; Johnston AM; Talaulikar D; Karpe K; Bhattacharyya A; Cheah CY; Subramoniapillai E; Bokhari W; Lee C; Hawkes EA; Jabbour A; Strasser SI; Chadban SJ; Brown C; Mollee P; Hapgood G, 2021, 'Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study from the Australasian Lymphoma Alliance', HemaSphere, 5, pp. E648, http://dx.doi.org/10.1097/HS9.0000000000000648

Farooq F; Cardonick E; Polushkina E; Ahmed S; Ramakrishnan P; Olszewski AJ; Yasin H; Hamad N; Lin Y; Edmonds J; Ciavolino L; Maggen C; Fruscio R; Gziri MM; Steffensen KD; Farooq U; Amant F; Sharon E; Yin T; Figg WD; Brandt J; Peer C; Vose JM; Evens AM, 2021, 'A Multi-Institution Analysis of Relapsed Lymphoma Occurring during Pregnancy Including Pharmacokinetics with Antenatal Checkpoint Inhibitor Therapy', Blood, 138, pp. 2457 - 2457, http://dx.doi.org/10.1182/blood-2021-149220

Dickinson M; Hamad N; Bryant CE; Borthakur G; Hosing C; Shook D; Tan J; Rajangam K; Liu H; Kennedy GA; McSweeney PA; Hill BT, 2021, 'A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with B-Cell Malignancies', Blood, 138, pp. 3868 - 3868, http://dx.doi.org/10.1182/blood-2021-146602

Abadir E; Othman J; Kwan J; Gottlieb DJ; Kennedy GA; Bajel A; Doocey R; Perera T; Watson A-M; Bardy PG; Greenwood M; Curtis DJ; Tran S; Moore J; Hamad N, 2021, 'Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with AML/MDS Demonstrates Excellent Long Term Overall Survival, Results from the Australasian Bone Marrow Transplant Recipient Registry', Blood, 138, pp. 2929 - 2929, http://dx.doi.org/10.1182/blood-2021-149939

Mills G; Moore J; Cliff E; Fong CY; Mangalasseril S; Tiley C; Gilbertson M; Ku M; Bazargan A; Bryson M; Menzies Wojtowicz M; Sungala NP; Cunningham I; Tang C; Hamad N, 2021, 'Promising Real World Survival Data in Adult-Onset Langerhans Cell Histiocytosis: An Australasian Lymphoma Alliance 20 Year Retrospective Study', Blood, 138, pp. 2570 - 2570, http://dx.doi.org/10.1182/blood-2021-152131

Novitzky-Basso I; Linn SM; White J; Elemary M; Xenocostas A; Hamad N; Tan S; Culos S; Law A; Kim DDH, 2021, 'Propensity Score Matching Analysis Comparing Ruxolitinib Vs Historical Controls in 2 nd Line or Beyond Treatment for Chronic Gvhd after Therapy Failure', Blood, 138, pp. 1805 - 1805, http://dx.doi.org/10.1182/blood-2021-151683

Walker SK; Harrop S; Di Ciaccio P; Lewis KL; Boles R; Tedjaseputra A; Hamad N; Hodges G; Yannakou CK; Tam CS; Opat S; Cheah CYY; Ku M, 2021, 'Real World Data on the Outcomes of Richter's Transformation of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma in the Australian Population: An Australasian Lymphoma Alliance Study', Blood, 138, pp. 1455 - 1455, http://dx.doi.org/10.1182/blood-2021-147146

Lim KJC; Di Ciaccio P; Hamad N; Polizzotto MN; Milliken S; Cochrane T; Goh Z; Shaw B; Perry E; Gilbertson M; Kermode W; Cheah CY; Latimer M; Ku M, 2021, 'Real-World Outcomes of Aggressive B-Cell Non-Hodgkin Lymphoma in People Living with HIV (PLWH) Treated in Australia: An Australasian Lymphoma Alliance Study', Blood, 138, pp. 1456 - 1456, http://dx.doi.org/10.1182/blood-2021-144817

Minson A; Hamad N; Yannakou CK; Wong SM; Butler JP; Seymour JF; Dickinson M, 2021, 'Trial in Progress: A Multicentre, Parallel Arm, Open-Label Trial of Frontline R-CHOP/Polatuzumab Vedotin-RCHP and Glofitamab in Younger Patients with Higher Risk Diffuse Large B Cell Lymphoma (COALITION)', Blood, 138, pp. 3571 - 3571, http://dx.doi.org/10.1182/blood-2021-147636

Chai KL; Wellard C; Moore EM; Augustson B; Bapat A; Blacklock HA; Cooke RE; Forsyth C; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge IH; King T; McCaughan GJ; Mollee P; Morrissey O; Murphy NE; Quach H; Tan XN; Wong K; Spencer A; Wood EM; McQuilten Z, 2021, 'Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)', Blood, 138, pp. 4757 - 4757, http://dx.doi.org/10.1182/blood-2021-147622

Cashman H; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S; Withers B; Lavee O; Milliken S; Moore J; Hamad N, 2021, 'Integrated electronic health record facilitates a safer and more efficient rural outreach haematology service', Internal Medicine Journal, 51, pp. 1869 - 1875, http://dx.doi.org/10.1111/imj.14973

R Di Ciaccio P; Emmett L; Hamad N, 2021, 'Qualitative study of nuclear medicine physicians' perceptions of positron emission tomography/computed tomography in pregnant patients with cancer', Internal Medicine Journal, 51, pp. 1722 - 1726, http://dx.doi.org/10.1111/imj.15515

Di Ciaccio PR; Mills G; Tang C; Hamad N, 2021, 'Managing haematological malignancies in pregnant women', The Lancet Haematology, 8, pp. e623 - e624, http://dx.doi.org/10.1016/S2352-3026(21)00242-8

MacIntyre CR; Veness B; Berger D; Hamad N; Bari N, 2021, 'Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination – A risk–benefit analysis for people < 60 years in Australia', Vaccine, 39, pp. 4784 - 4787, http://dx.doi.org/10.1016/j.vaccine.2021.07.013

Hamad N; Ananda-Rajah M; Gilroy N; MacIntyre R; Gottlieb D; Ritchie D; Harrison S; Kennedy G; Watson AM; Greenwood M; Doocey R; Perera T; Spencer A; Wong E; O'Brien T; Shaw P; Conyers R; Milliken S; Bardy P; Larsen S; Ho PJ; Lai H; Bajel A; Butler J; Tiley C; D'Rozario J; Johnston A; Cochrane T; Mills T; Irving I; Pullon H; Purtill D, 2021, 'Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement', Internal Medicine Journal, 51, pp. 1321 - 1323, http://dx.doi.org/10.1111/imj.15263

Zeiser R; Polverelli N; Ram R; Hashmi SK; Chakraverty R; Middeke JM; Musso M; Giebel S; Uzay A; Langmuir P; Hollaender N; Gowda M; Stefanelli T; Lee SJ; Teshima T; Locatelli F, 2021, 'Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease', NEW ENGLAND JOURNAL OF MEDICINE, 385, pp. 228 - 238, http://dx.doi.org/10.1056/NEJMoa2033122

Scordo M; Wang TP; Ahn KW; Chen Y; Ahmed S; Awan FT; Beitinjaneh A; Chen A; Chow VA; Dholaria B; Epperla N; Farooq U; Ghosh N; Grover N; Hamad N; Hildebrandt GC; Holmberg L; Hong S; Inwards DJ; Jimenez-Jimenez A; Karmali R; Kenkre VP; Khimani F; Klyuchnikov E; Krem MM; Munshi PN; Nieto Y; Prestidge T; Ramakrishnan Geethakumari P; Rezvani AR; Riedell PA; Seo S; Shah NN; Solh M; Yared JA; Kharfan-Dabaja MA; Herrera A; Hamadani M; Sauter CS, 2021, 'Outcomes Associated with Thiotepa-Based Conditioning in Patients with Primary Central Nervous System Lymphoma after Autologous Hematopoietic Cell Transplant', JAMA Oncology, 7, pp. 993 - 1003, http://dx.doi.org/10.1001/jamaoncol.2021.1074

Tang C; Hamad N, 2021, 'Trials and tribulations: including women in cancer clinical research', The Lancet Haematology, 8, pp. e477 - e478, http://dx.doi.org/10.1016/S2352-3026(21)00165-4

McCaughan G; Di Ciaccio P; Ananda-Rajah M; Gilroy N; MacIntyre R; Teh B; Weinkove R; Curnow J; Szer J; Enjeti AK; Ross DM; Mulligan S; Trotman J; Dickinson M; Quach H; Choi P; Polizzotto MN; Tam CS; Ho PJ; Ku M; Gregory G; Gangatharan S; Hapgood G; Cochrane T; Cheah C; Gibbs S; Wei A; Johnston A; Greenwood M; Prince HM; Latimer M; Berkahn L; Wight J; Armytage T; Hamad N, 2021, 'COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement', Internal Medicine Journal, 51, pp. 763 - 768, http://dx.doi.org/10.1111/imj.15247

Shah J; Shacham S; Kauffman M; Daniele P; Tomaras D; Tremblay G; Casasnovas RO; Maerevoet M; Zijlstra J; Follows G; P Vermaat JS; Kalakonda N; Goy AH; Choquet S; Den Neste EV; Hill BT; Thieblemont C; Cavallo F; La Cruz FD; Kuruvilla J; Hamad N; Bouabdallah R; Jäger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vasilakopoulos TP; Samal P; Nagy A; Ku M; Canales Albendea MÁ, 2021, 'Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma', Future Oncology, 17, pp. 1295 - 1310, http://dx.doi.org/10.2217/fon-2020-0946

Ross DM; Thomson C; Hamad N; Lane SW; Manos K; Grigg AP; Guo B; Erber WN; Scott A; Viiala N; Chee L; Latimer M; Tate C; Grove C; Perkins AC; Blombery P, 2021, 'Myeloid somatic mutation panel testing in myeloproliferative neoplasms', Pathology, 53, pp. 339 - 348, http://dx.doi.org/10.1016/j.pathol.2021.01.003

Lewis KL; Chin CK; Manos K; Casey J; Hamad N; Crawford J; Ho SJ; Issa S; Grigg A; Wood P; Gandhi MK; Do B; Nastoupil L; Hawkes EA; Cheah CY, 2021, 'Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience', British Journal of Haematology, 192, pp. 1049 - 1053, http://dx.doi.org/10.1111/bjh.16946

Connolly EA; Weickhardt AJ; Grimison PS; Heller G; Lewin JH; Liow ECH; Tung I; Tran B; Hill S; Walpole ET; McKenzie J; Kuchel A; Forgeson G; Tan ABT; Joshi A; Wickham A; Tan TH; Wang Y; Hamad N; Wong V, 2021, 'Australia and New Zealand (ANZ) outcomes of high-dose chemotherapy and stem cell transplantation for relapsed or refractory germ cell tumors (GCT) from 1999 to 2019: Multicenter registry-based study with ABMTRR.', JOURNAL OF CLINICAL ONCOLOGY, 39, http://dx.doi.org/10.1200/JCO.2021.39.6_suppl.382

Blennerhassett R; Purtill D; Hamad N, 2021, 'Letter to the Editor Regarding “Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia”', Transplantation and Cellular Therapy, 27, pp. 190 - 191, http://dx.doi.org/10.1016/j.jtct.2020.11.011

Di Ciaccio PR; Ritchie DS; Kennedy G; Milliken S; Purtill D; Gottlieb D; Perera T; Yeung DT; Larsen SR; Doocey RT; Greenwood M; Durrant S; Watson A-M; Butler A; Khot A; Curley C; Hamad N, 2021, 'Allogeneic Haematopoietic Cell Transplantation for Mantle Cell Lymphoma Can Achieve Durable Remission and Myeloablative Conditioning Is Associated with Inferior Survival: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S394 - S395, http://dx.doi.org/10.1016/s2666-6367(21)00509-1

Di Ciaccio PR; Greenwood M; Kennedy G; Milliken S; Gottlieb D; Ritchie DS; Purtill D; Larsen SR; Spencer A; Perera T; Yeung DT; Durrant S; Butler A; Watson A-M; Lai HC; Doocey RT; Goodman HJ; Kerridge IH; Arthur C; Curley C; Stewart C; Micklethwaite K; Collins J; Cooney JP; Hamad N, 2021, 'Allogeneic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Can Achieve Durable Remissions: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S394 - S394, http://dx.doi.org/10.1016/s2666-6367(21)00508-x

Barge L; Tran S; Kennedy G; Ritchie DS; Gottlieb D; Milliken S; Spencer A; Purtill D; Perera T; Doocey RT; Larsen S; Butler A; Bardy P; Greenwood M; Durrant S; Curley C; Stewart C; Tam CS; Collins J; Balendran S; Di Ciaccio PR; Patil S; Han M-H; Hamad N, 2021, 'Improvement in Non-Relapse Mortality Following Allogeneic Transplantation for Chronic Lymphocytic Leukaemia in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S133 - S135, http://dx.doi.org/10.1016/s2666-6367(21)00168-8

Lwin Y; Kennedy G; Gottlieb D; Kwan J; Ritchie D; Szer J; Milliken S; Browett P; Spencer A; Butler A; Bardy P; Greenwood M; Perera T; He S; McEwan A; Larsen S; Lai H; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry', Biology of Blood and Marrow Transplantation, 26, pp. 2252 - 2261, http://dx.doi.org/10.1016/j.bbmt.2020.08.024

Wang J; Asch AS; Hamad N; Weickhardt A; Tomaszewska-Kiecana M; Dlugosz-Danecka M; Pylypenko H; Bahadur S; Ulahannan S; Koucheki J; Sun J; Li H; Chen F; Zhang X; Muth J; Kaminker P; Moore P; Sumrow BJ, 2020, 'A Phase 1, Open-Label Study of MGD013, a Bispecific DART® Molecule Binding PD-1 and LAG-3 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma', Blood, 136, pp. 21 - 22, http://dx.doi.org/10.1182/blood-2020-139868

Minson A; Hamad N; Butler JP; Westerman DA; Ritchie D; Blombery P; Seymour JF; Tam CS; Dickinson M, 2020, 'A Phase II, Open-Label, Single Arm Trial to Assess the Efficacy and Safety of the Combination of Tisagenlecleucel and Ibrutinib in Mantle Cell Lymphoma (TARMAC)', Blood, 136, pp. 34 - 35, http://dx.doi.org/10.1182/blood-2020-138946

Moore J; Kwan J; Gottlieb D; Bajel A; Ritchie D; Yeung DT; Greenwood M; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'A Prospective Haploidentical Peripheral Blood Stem Cell Transplant Study Using a Pre-Defined Conditioning Regimen Intensity Based on Age and the Hematopoietic Cell Transplantation Comorbidity Index- Anzhit 1: Encouraging Preliminary Survival Outcomes at One Year Follow up', Blood, 136, pp. 51 - 52, http://dx.doi.org/10.1182/blood-2020-142131

Back to profile page